|By PR Newswire||
|March 18, 2014 06:04 PM EDT||
NEW YORK, March 18, 2014 /PRNewswire/ -- (PR Newswire) – FRANK & BIANCO LLP is investigating potential securities fraud claims against Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) and certain of its officers, on behalf of purchasers of Geron's securities between June 16, 2013 and March 11, 2014, inclusive (the "Class Period").
The investigation concerns possible violations of the federal securities laws that occurred when the Company and certain of its officers issued materially false and misleading statements or omitted to state material information during the Class Period regarding imetelstat, Geron's first-in-class telomerase inhibitor currently in development for the treatment of hematologic malignancies. As a result of these misstatements and omissions, Geron's securities traded at artificially inflated prices throughout the Class Period.
On March 12, 2014, the Company issued a press release announcing that the U.S. Food and Drug Administration ("FDA") had halted clinical trials of imetelstat. The FDA cited concerns about persistent liver function test ("LFT") abnormalities reported in patients participating in clinical trials, and the potential risk of chronic liver injury following long-term exposure to the drug. In addition, the FDA expressed concern about whether the reported LFT abnormalities are reversible. On this news, the Company's stock price dropped $2.71 per share, more than 60%, on heavy trading volume.
If you purchased Geron securities within the Class Period, and you wish to discuss this investigation, or have any questions concerning this notice or your rights or interests with respect to these matters, please contact us.
SOURCE Frank & Bianco LLP
Aug. 26, 2016 09:15 PM EDT Reads: 1,419
Aug. 26, 2016 07:15 PM EDT Reads: 378
Aug. 26, 2016 07:00 PM EDT Reads: 673
Aug. 26, 2016 07:00 PM EDT Reads: 640
Aug. 26, 2016 06:00 PM EDT Reads: 1,914
Aug. 26, 2016 05:00 PM EDT Reads: 663
Aug. 26, 2016 04:45 PM EDT Reads: 1,525
Aug. 26, 2016 04:30 PM EDT Reads: 2,297
Aug. 26, 2016 04:00 PM EDT Reads: 3,927
Aug. 26, 2016 03:45 PM EDT Reads: 551
Aug. 26, 2016 03:15 PM EDT Reads: 410
Aug. 26, 2016 01:30 PM EDT Reads: 3,410
Aug. 26, 2016 01:00 PM EDT Reads: 1,973
Aug. 26, 2016 12:30 PM EDT Reads: 634
Enterprises have forever faced challenges surrounding the sharing of their intellectual property. Emerging cloud adoption has made it more compelling for enterprises to digitize their content, making them available over a wide variety of devices across the Internet. In his session at 19th Cloud Expo, Santosh Ahuja, Director of Architecture at Impiger Technologies, will introduce various mechanisms provided by cloud service providers today to manage and share digital content in a secure manner....
Aug. 26, 2016 11:45 AM EDT Reads: 669